Grant to revolutionize the future treatment of brain disorders
TORONTO, Feb. 26, 2020 /CNW/ - On March 2, 2020, please join us for a press conference hosted at Sunnybrook Health Sciences Centre, to learn more about a one-of-a-kind philanthropic grant in support of focused ultrasound research.
With a landmark grant, Sunnybrook is set to revolutionize the future treatment of brain disorders such as Alzheimer's, brain cancer and ALS. This grant will accelerate focused ultrasound research and innovation in Canada, making it possible to bring this groundbreaking technology to more patients across the globe, faster.
The creative grant structure is significant in its own right. It serves as a new template for philanthropic grant-making in Canada, one that may be scaled and modeled by other Canadian charitable foundations for the purposes of fueling discovery and potential reinvestment in homegrown innovation.
Join us as we launch a new focused ultrasound initiative at Sunnybrook and reveal the future of personalized medicine.
When: Monday, March 2, 2020, 9:45 - 11:00 AM
Remarks will begin promptly at 9:45 AM
Photo and interview opportunities with the lead donor and key Sunnybrook spokespeople to commence at 11:00 AM.
Where: Sunnybrook Health Sciences Centre
2075 Bayview Ave, Toronto, ON
Media: Please meet at the M-Wing, First Floor Main Entrance by the volunteer gift shop.
Who: Interview opportunities with:
- Lead donor
- Dr. Andy Smith, President & CEO, Sunnybrook Hospital
- Dr. Jon Dellandrea, President & CEO, Sunnybrook Foundation
- Dr. Kullervo Hynynen, Vice-president, Research & Innovation, Sunnybrook Hospital
SOURCE Sunnybrook Health Sciences Centre
For further information: For more information or interview requests please contact Jennifer Palisoc, Communications Advisor, Sunnybrook Health Sciences Centre, 416-480-4040, [email protected]